CA
GNOM icon

Corrado Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Corrado Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,831
Closed -$731K – 107
2024
Q4 		$731K Buy
18,831
+2,775
+17% +$117K 0.48% 81
2024
Q3 		$723K Buy
16,056
+473
+3% +$21.1K 0.45% 79
2024
Q2 		$651K Buy
15,583
+973
+7% +$40.7K 0.42% 83
2024
Q1 		$665K Buy
14,610
+808
+6% +$36.8K 0.44% 75
2023
Q4 		$638K Buy
+13,802
New +$563K 0.52% 61

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return